About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
https://soho2018.org/
Session I: Chronic Myeloid Leukemia
Session II: Myelodysplastic Syndromes
Session III: Myeloproliferative Neoplasms
Session IV: Acute Lymphoblastic Leukemia
Session V: Acute Myeloid Leukemia
Plenary Sessions
Breakfast with the Expert
Session VI: Multiple Myeloma
Program of Events
Session VIII: Non-Hodgkin Lymphoma
Session IX: Chronic Lymphocytic Leukemia
Session X: Research Topics
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Oral Abstract CML-044: Treatment-Free Remission (TFR) in Patients with Chronic-Phase Chronic Myeloid Leukemia (CML-CP) and Stable Deep Molecular Response (DMR) Discontinuing Dasatinib
By
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
FEATURING
Michael J. Mauro
By
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
FEATURING
Michael J. Mauro
9 views
November 5, 2018
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Session I: Chronic Myeloid Leukemia
19:21
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
CML: State of the Art Update
Feat.
J. Cortés
17:26
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
ELN v NCCN: Do We Have Consensus?
Feat.
C. Schiffer
14:23
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Case Studies in TFR
Feat.
D. Rea
16:17
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
When Second Generation TKIs Fail
Feat.
J. Radich
13:54
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
DEBATE: Second Generation TKIs Are The Preferred Frontline Treatment…
Feat.
G. Saglio
15:41
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
DEBATE: Second Generation TKIs Are The Preferred Frontline Treatment…
Feat.
J. Apperley
17:02
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Advanced CML Phase Disease: Current Management
Feat.
M. Deininger
06:09
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Oral Abstract CML-057: ENESTop 144-Week Update: Long-Term Treatment-…
Feat.
T. Hughes
07:46
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Oral Abstract CML-044: Treatment-Free Remission (TFR) in Patients wi…
Feat.
M. Mauro
12:10
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
CML: Next Questions
Feat.
T. Hughes
